2018. ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients. Clinics. 73, (Jan. 2018), e1err. DOI:https://doi.org/10.6061/clinics/2018/e1err.